Spineway SA engages in the design, manufacture, and marketing of implants and instruments for the treatment of spinal pain. The company offers posterior fixation, including posterior osteosynthesis systems; veos titanium is a top-loading posterior osteosynthesis system; veos peek-optima image contrast is a top-loading posterior fixation system offering the possibility to perform semi-rigid posterior fixation; kaphorn is a side loading posterior osteosynthesis system; Mont Blanc mis, is a complete implant system for thoraco-lombo-sacral posterior osteosynthesis; Mont Blanc, is a consist of various forms and sizes of screws, locking screws, rods, hooks and connectors. It also provides interbody fusion, including lumbar cage twin peaks tilf oblique, and curved; stand-alone cervical cage acifbox; secured cervical cage ; cervical plate-cage; cervical plate-cage; and cage acifbox. In addition, the company offers motion preservation, which includes cervical prosthesis cp-esp and lumbar prosthesis lp-esp. Further, it provides biomaterials, such as hydroxyapatite nanoparticle gel neve. The company exports its products. Spineway SA was incorporated in 2005 and is headquartered in Ecully, France.
Metrics to compare | ALSPW | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALSPWPeersSector | |
---|---|---|---|---|
P/E Ratio | −0.6x | −1.6x | −0.5x | |
PEG Ratio | −0.01 | −0.01 | 0.00 | |
Price/Book | 0.1x | 1.5x | 2.6x | |
Price / LTM Sales | 0.2x | 1.1x | 3.2x | |
Upside (Analyst Target) | 191.3% | 46.7% | 43.8% | |
Fair Value Upside | Unlock | 12.6% | 5.1% | Unlock |